Partner
Bertil Lindmark
Venture Partner, XGen Ventures
- Firm
- XGen Ventures
- Title
- Venture Partner
- Role
- Venture partner
- Location
- Copenhagen, (DK)
- Known as
- Investor
Claim, correct or request removal
Record updated 17 September 2026
About
Bertil Lindmark joined XGEN as Venture Partner in 2023. Professor Lindmark has a long and successful career in bio pharma with leading global roles in AstraZeneca and Almirall as well as in several biotech companies. His focus in respiratory, immunology and cancer has led to global drug approvals and successful launches. He has also been involved in several IPOs, major funding events and acquisitions. Among other roles, he currently holds the position of Chairman of the Board at Aqilion AB and Chief Medical officer at Galecto Inc (NASDAQ: GLTO). Professor Lindmark received his PhD in molecular epidemiology from Lund University, Sweden.
Is this you? Remove my profile
Loading relationship preview